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Abstract
Snakebite is a major neglected tropical health issue that affects over 5 million people world-
wide resulting in around 1.8 million envenomations and 100,000 deaths each year. Snake-
bite envenomation also causes innumerable morbidities, specifically loss of limbs as a result
of excessive tissue/muscle damage. Snake venom metalloproteases (SVMPs) are a pre-
dominant component of viper venoms, and are involved in the degradation of basement
membrane proteins (particularly collagen) surrounding the tissues around the bite site.
Although their collagenolytic properties have been established, the molecular mechanisms
through which SVMPs induce permanent muscle damage are poorly understood. Here, we
demonstrate the purification and characterisation of an SVMP from a viper (Crotalus atrox)
venom. Mass spectrometry analysis confirmed that this protein is most likely to be a group
III metalloprotease (showing high similarity to VAP2A) and has been referred to as CAMP
(Crotalus atrox metalloprotease). CAMP displays both collagenolytic and fibrinogenolytic
activities and inhibits CRP-XL-induced platelet aggregation. To determine its effects on
muscle damage, CAMP was administered into the tibialis anterior muscle of mice and its
actions were compared with cardiotoxin I (a three-finger toxin) from an elapid snake (Naja
pallida) venom. Extensive immunohistochemistry analyses revealed that CAMP significantly
damages skeletal muscles by attacking the collagen scaffold and other important basement
membrane proteins, and prevents their regeneration through disrupting the functions of sat-
ellite cells. In contrast, cardiotoxin I destroys skeletal muscle by damaging the plasma mem-
brane, but does not impact regeneration due to its inability to affect the extracellular matrix.
Overall, this study provides novel insights into the mechanisms through which SVMPs
induce permanent muscle damage.
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Author summary
Snakebite is a major neglected tropical disease that affects thousands of people in the rural
areas of developing countries. As well as the deaths, snakebites result in a significant num-
ber of disabilities including permanent loss of limbs that alter the lifestyle of the victims.
Snake venom is a mixture of different proteins with diverse functions; one of these major
protein groups present in viper venoms are metalloproteases that primarily induce muscle
damage. The mechanisms behind the development of snakebite (metalloprotease)-
induced permanent muscle damage are poorly studied. Here, we have purified a metallo-
protease (CAMP) from the venom of the Western diamondback rattlesnake, and charac-
terised its function in mice. To determine the actions of CAMP in the development of
permanent muscle damage, it was injected into the muscle of mice in a parallel compari-
son with cardiotoxin I (from the venom of the Red spitting cobra). The effects of these
proteins on muscle regeneration were analysed at 5 and 10 days after injection. The results
demonstrate that through a combination of effects on the structural scaffolds surrounding
the tissues, blood vessels and regeneration, CAMP significantly affects the muscles,
thereby leading to permanent muscle damage.
Introduction
Snakebite envenomation is a recently reinstated neglected tropical disease [1] that causes
around 100,000 deaths annually [2, 3] and innumerable permanent disabilities predominantly
on the rural population living in the lower income regions of the world [4–6]. The significant
rate of mortality and morbidity occurs due to the difficulties associated with the treatment of
snakebites [7], which vary depending on the species [8], geographical location [9], age of the
offending snake [10, 11], the quantity of venom injected, correct diagnosis and mode of treat-
ment [12]. Snake venoms contain proteins and small peptides with diverse functional effects
[12]. Medically important snakes are generally found in two main families; Elapidae, a family
with venoms mainly composed of smaller, neurotoxic proteins such as phospholipase A2
(PLA2) and three finger toxins, and Viperidae, a family with generally larger proteins such as
serine and metalloproteases that primarily affect the cardiovascular and musculoskeletal sys-
tems. Snake venom serine proteases (SVSPs) mainly cause systemic envenomation effects such
as the alteration of blood pressure, activation or inhibition of coagulation factors and degrada-
tion of fibrinogen [13, 14]. However, snake venom metalloproteases (SVMPs) primarily
induce local envenomation effects such as swelling, necrosis and extensive tissue/muscle dam-
age as well as the activation of certain coagulation factors and degradation of fibrinogen.
SVMP-induced muscle damage is often difficult to treat due to the delay in obtaining appro-
priate medical treatment and poor outcome of anti-snake venom (ASV) treatment in the local
tissues [15, 16]. Hence, extensive tissue damage is frequently treated by fasciotomy, a surgical
procedure to remove the damaged tissues, cleaning the affected areas followed by skin graft or
amputation of affected limbs or fingers when fasciotomy fails to suffice [7]. This results in per-
manent disabilities for victims, and significantly affects their socio-economic status following
snakebites. For example, long term (persisting for over 13 years) musculoskeletal disabilities
were found in over 3% of snakebite victims in a rural population of Sri Lanka and of these over
15% had to undergo amputations [17].
Skeletal muscle is composed of myofibres surrounded by the collagen-rich basement mem-
brane. This tissue is imbued with a resident stem cell population called satellite cells (SCs),
located under that basement membrane (BM), which are able to regenerate a functional tissue
even after extensive damage [18]. The BM plays a key role in muscle repair by orientating the
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regenerating myofibres, a process mediated by SCs and acting as a scaffold for fibres to grow
parallel to the existing fibres [19]. The majority of the direct myotoxic effects of venoms are
attributed to PLA2 [20]. They can induce either local or systemic effects depending on their
specificity to muscle cells (systemic effects) or a broader range of cells (local effects) through
hydrolysis of phospholipids in plasma membrane. Other myotoxic venom components
include sodium channel-blocking myotoxins [21] and muscle fibre depolarising cardiotoxins
[22]. SVMPs are enzymatic proteins that primarily attack the collagenous structures and vari-
ous other important components of BM to induce muscle damage. It has recently been
reported that SVMPs induce haemorrhage by cleaving components of the BM and extracellu-
lar matrix surrounding the smaller blood vessels [23] although as multi-domain proteins, they
are capable of binding to and cleaving a range of different proteins [24, 25].
SVMPs are generally classified into four groups based on the additional domains present in
their structure: PI/Group I—contains only a metalloprotease domain; PII/Group II—contains
a metalloprotease and disintegrin domain, and in some cases the disintegrin domain has been
reported to be processed and liberated as a free disintegrin; PIII/Group III—contains a metal-
loprotease, a disintegrin-like and cysteine-rich domains; PIV/Group IV—contains two lectin-
like domains connected by disulphide bonds to the other domains that are found in PIII
SVMPs [26]. Although disintegrin-like domains show high sequence identity to disintegrins,
they lack the typical RGD motif found in the venom disintegrins, which inhibit platelet aggre-
gation via selectively blocking integrins. Both disintegrin-like and cysteine-rich domains have
been found to inhibit collagen-induced platelet aggregation and induce early events of acute
inflammation [27]. Notably, disintegrin-like domains were reported to contain an ECD motif
that interacts with integrins and block their functions [28]. The non-proteinase domains play
key roles in determining the diverse pharmacological effects of PII, PIII and PIV classes of
SVMPs including the activation of coagulation factor X [29] and prothrombin [30] amongst
others. These domains have also been found to co-localise in muscles, facilitating the hydroly-
sis of collagen and other BM components by the metalloprotease domain and promoting its
accumulation in the BM [24], exerting haemotoxic activities. Moreover, SVMPs are also
known to cause ischaemia in the local tissues due to poor blood supply as a result of their hae-
motoxic effects [31], which may prevent phagocytic removal of necrotic debris and reduce the
supply of oxygen and nutrients needed for regeneration [32]. Given the complexity of their
actions, a better understanding of the molecular mechanisms through which SVMPs induce
permanent muscle damage may pave the way to the development of improved therapeutic
strategies for snakebites. In this study, we demonstrate novel insights into the mechanisms by
which a PIII/group III metalloprotease isolated from the venom of a North American viper,
the western diamondback rattlesnake, Crotalus atrox triggers permanent muscle damage. Our
results establish that this SVMP induces muscle damage and also prevents muscle regeneration
by acting on the BM, myofibres, blood supply and SCs.
Materials and methods
Materials
Lyophilised C. atrox venom was purchased from Sigma Aldrich (UK) and the purified Cardio-
toxin 1 (CTX), a three-finger toxin from the venom of Naja pallida was obtained from Latoxan
(France).
Protein purification
C. atrox venom (10mg) was dissolved in 1mL of 20mM Tris.HCl buffer (pH 7.6) and centri-
fuged at 5000g for 5 minutes before applying to a pre-made 1mL HiTrap™ Q HP Sepharose
Snake venom metalloprotease-induced permanent muscle damage
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anion exchange column. Protein elution was performed at a rate of 1mL/min using 1M NaCl/
20mM Tris.HCl gradient (up to 60%) by an A¨KTA purifier system (GE Healthcare, UK) over
20 minutes. The collected fractions were analysed by SDS-PAGE using standard protocols as
described previously [33] and fractions with the protein of interest were pooled. The pooled
fractions were then concentrated using a Vivaspin centrifugal filter and applied to a gel filtra-
tion column (Superdex 75, 1.6cm x 70cm). Protein elution was performed at a rate of 1mL/
min using 20mM Tris.HCl (pH 7.6). Following SDS-PAGE analysis, the fractions containing
the protein of interest were pooled and concentrated before running through the same gel fil-
tration column again for further purification. Finally, the fractions containing the pure protein
were pooled, concentrated and stored at -80˚C until further use. Protein estimation was per-
formed using Coomassie plus protein assay reagent (ThermoFisher Scientific, UK) and bovine
serum albumin as standards.
Mass spectrometry
The purified protein was subjected to SDS-PAGE, and a gel section containing the pure pro-
tein was subjected to tryptic digestion and analysed by mass spectrometry at AltaBioscience
(Birmingham, UK). The extracted protein (10μg) from the gel slice was added to 100mM
ammonium bicarbonate (pH 8). This was then incubated with dithiothreitol (10mM) at 56˚C
for 30 minutes. After cooling to room temperature, the cysteine residues were alkylated using
iodoacetamide (50mM). Trypsin gold (Promega, UK) was subsequently added and the samples
were incubated overnight at 37˚C. The digested peptides were concentrated and separated
using an Ultimate 3000 HPLC series (Dionex, USA). Samples were then trapped on an
Acclaim PepMap 100 C18 LC column, 5um, 100A 300um i.d. x 5mm (Dionex, USA), then fur-
ther separated in Nano Series Standard Columns 75μm i.d. x 15 cm. This was packed with C18
PepMap100 (Dionex, USA) and a gradient from 3.2% - 44% (v/v) solvent B (0.1% formic acid
in acetonitrile) over 30 minutes was used to separate the peptides. The digested peptides were
eluted (300nL/min) using a triversa nanomate nanospray source (Advion Biosciences, USA)
into a LTQ Orbitrap Elite Mass Spectrometer (ThermoFisher Scientific, Germany). The MS
and MS/MS data were then searched against Uniprot using Sequest algorithm and the partial
sequence was then compared to the other similar protein sequences available in the protein
database.
Fibrinogenolytic assay
Human plasma fibrinogen (100μg/mL) was incubated with different concentrations of the
whole venom or the purified protein, and a small volume of digested samples were removed at
30, 60, 90 and 120 minutes and mixed with reducing sample treatment buffer [4% (w/v) SDS,
10% (v/v) β-mercaptoethanol, 20% (v/v) Glycerol and 50mM Tris.HCl, pH 6.8]. The samples
were then analysed by 10% SDS-PAGE and stained with Coomassie brilliant blue to determine
the fibrinogenolytic activity of venom and the purified protein.
Enzymatic assays
The metalloprotease activity of both C. atrox whole venom and the purified protein was
assessed using a fluorogenic substrate, DQ-gelatin (ThermoFisher Scientific, UK). Briefly, the
whole venom or purified protein (10μg/mL) was mixed in phosphate buffered saline (PBS, pH
7.4) with DQ gelatin (10μg/mL). The reaction mix was incubated at 37˚C and the level of fluo-
rescence was measured at 60 minutes using an excitation wavelength of 485nm and emission
wavelength of 520nm by spectrofluorimetry (FLUOstar OPTIMA, Germany).
Snake venom metalloprotease-induced permanent muscle damage
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Similarly, the serine protease activity was measured using a selective substrate, Nα-Benzoyl-
L-Arginine-7-Amido-4-methylcoumarin hydrochloride (BAAMC) (Sigma Aldrich, UK). The
whole venom or the purified protein (10μg/mL) was incubated with BAAMC (2μM) at 37˚C
and the level of fluorescence was measured at an excitation wavelength of 380nm and emission
wavelength of 440nm by spectrofluorimetry.
Ethical statement
The University of Reading Research Ethics Committee has approved the procedures for blood
collection from healthy human volunteers and the consent forms used to obtain written con-
sent. Experiments with mice were performed in line with the principles and guidelines of the
British Home Office and the Animals (Scientific Procedures) Act 1986 (PPL70/7516). All the
procedures were approved by the University Research Ethics Committee (License number:
UREC 17/17).
Platelet aggregation
Human blood was obtained from healthy volunteers in vacutainers with 3.2% (w/v) sodium
citrate as an anti-coagulant and the platelet-rich plasma (PRP) was prepared as described pre-
viously [34–36]. Platelet aggregation assays were performed by optical aggregometry using
0.5μg/mL cross-linked collagen related peptide (CRP-XL) as an agonist in the presence and
absence of different concentrations of the purified protein.
Administration of CTX or the purified protein in mice
The C57BL/6 mice (8 weeks old) were obtained from Envigo, UK. Mice were anaesthetised
with 3.5% (v/v) isofluorane in oxygen before maintaining at 2% for the procedure. They were
then injected intramuscularly with 30μL of either PBS (undamaged control), 50μM CTX, and
8 or 16 μM of the purified protein into their right tibialis anterior muscle. Mice were then
allowed to recuperate for either 5 or 10 days before sacrificing by carbon dioxide asphyxiation
and cervical dislocation.
Dissection of tibialis anterior (TA) and extensor digitorum longus (EDL)
The TA muscles from mice were dissected, weighed and frozen on liquid nitrogen cooled iso-
pentane prior to storage at -80˚C. The EDL muscle was dissected from the undamaged contra-
lateral hind limb of experimental mice and immediately placed in a 2mg/mL collagenase solu-
tion (Sigma Aldrich, UK) and incubated at 37˚C with 5% CO2 for 2 hours to isolate the single
fibres as previously described [37].
Proliferation and migration of satellite cells
To determine the proliferation of SCs and myogenic differentiation, isolated single fibres were
cultured for up to 48 hours at 37˚C with 5% CO2 in single fibre culture medium (SFCM—
DMEM, 10% (v/v) horse serum, 1% (v/v) penicillin-streptomycin and 0.5% (v/v) chick embryo
extract) supplemented with either 0, 0.3, 1 or 3 μM of the purified protein prior to fixation in
2% (w/v) paraformaldehyde in PBS and maintained in PBS prior to immunocytochemistry.
The migration of muscle fibre SCs was analysed as described previously [37]. Briefly, the
isolated single fibres were cultured for 24 hours in SFCM before transferring to SFCM contain-
ing 0, 0.3, 1 or 3μM of the purified protein and monitoring by a phase contrast microscope at
37˚C with 5% CO2 using a 10X objective. A time-lapse video was captured at a rate of 1 frame
every 15 minutes for a 24-hour period and analysed to determine the rate of migration.
Snake venom metalloprotease-induced permanent muscle damage
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Immunohistochemistry
The collected TA muscles were mounted in Tissue-TEK1OCT compound in an orientation
allowing the transverse sections of 13μm thickness to be obtained using a cryo microtome. The
tissue sections were incubated in permeabilisation buffer [20mM HEPES, 3mM MgCl2, 50mM
NaCl, 0.05% (w/v) sodium azide, 300mM sucrose and 0.5% (v/v) Triton X-100] for 15 minutes
at room temperature. To remove the excess permeabilisation buffer, 3 x 5 minute washes were
performed using PBS before the application of wash buffer [PBS with 5% fetal bovine serum
(v/v), 0.05% (v/v) Triton X-100] for 30 minutes at room temperature.
Primary antibodies were pre-blocked in wash buffer for 30 minutes prior to application
onto muscle sections overnight at 4˚C. In order to remove the primary antibodies, muscle sec-
tions were washed three times (5 minutes each) in wash buffer. The sections were then incu-
bated with species-specific secondary antibodies that were conjugated with Alexa Fluor 488 or
594. The secondary antibodies were pre-blocked in wash buffer for minimum of 30 minutes
before their application onto the slides and incubated for 1 hour in the dark at room tempera-
ture. Thereafter, the muscle sections were washed 3 x 5 minutes in PBS to remove the unbound
secondary antibodies. Finally, the slides were mounted in fluorescent mounting medium, and
the myonuclei were visualised using 4, 6-diamidino-2-phenylindole (DAPI) (2.5μg/mL). The
images of sections were obtained using a fluorescence microscope (Zeiss AxioImager) and
analysed using ImageJ. Macrophages were detected by F4.80 staining using the Vector Labora-
tories ImmPRESS Excel Staining Kit. A list of antibodies used in this study is provided in S1
Table.
Statistical analysis
All the statistical analyses were performed using GraphPad Prism 7 and the P-values were cal-
culated using one-way ANOVA followed by Dunnett’s post hoc multiple comparisons test.
Results
Protein purification and identification
In order to purify a protein with a molecular weight of around 50kDa (as predicted for group
III SVMPs) from the venom of C. atrox, a two-dimensional chromatography approach was
employed. Following the initial fractionation of venom via anion exchange chromatography
(Fig 1A and 1B), the selected fractions (14–18) with a highly abundant protein at approxi-
mately 50kDa were pooled and run through a gel filtration chromatography column (Fig 1C
and 1D). The fractions (62–67) were pooled and run through the same gel filtration column
again to refine the purification (Fig 1E and 1F). Finally, a pure protein with a molecular weight
of around 50kDa was isolated. Mass spectrometry characterisation of the tryptic digested pep-
tides of this protein and further Mascot analysis confirmed it to be a similar or identical pro-
tein to vascular apoptosis inducing proteins (VAP) such as VAP2, a protein with a molecular
weight of 55kDa (an identical molecular weight to the purified protein) [38], which is a group
III metalloprotease (Fig 1G). The identified peptide sequences of the purified protein covered
around 43% of the sequence of VAP2A (highlighted in red in Fig 1G). The purified protein has
been referred to as ‘CAMP’ to denote C. atrox metalloprotease throughout this article.
Fibrinogenolytic and collagenolytic activities of CAMP
By using fluorogenic substrates, the protease activity of CAMP was analysed in comparison to
the whole venom. CAMP displayed no serine protease activity as it failed to cleave a serine pro-
tease selective fluorogenic substrate, BAAMC although the whole venom displayed significant
Snake venom metalloprotease-induced permanent muscle damage
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serine protease activity (Fig 2A). However, it showed high levels (similar to the whole venom)
of collagenolytic activity (Fig 2B). Furthermore, the ability of CAMP to digest fibrinogen was
analysed by incubating it with human plasma fibrinogen. The SDS-PAGE analysis of samples
that were taken at different points of incubation confirmed that CAMP is capable of cleaving
Aα and Bβ chains of fibrinogen although it was unable to cleave the γ chain (Fig 2C). The
digestion of fibrinogen with CAMP appears to be rapid as the levels of Aα and Bβ chains of
fibrinogen were reduced significantly as early as 30 minutes of incubation. These results cor-
roborate CAMP as an SVMP with collagenolytic and fibrinogenolytic activities, which may
affect the collagen in the BM around the local tissues at the bite site and fibrinogen in the
blood.
CAMP inhibits human platelet aggregation
The ability of CAMP to inhibit agonist-induced platelet activation was analysed using human
platelet-rich plasma (PRP) by optical aggregometry. The pre-treatment of human platelets
(PRP) with CAMP (50μg/mL) has significantly inhibited 0.5μg/mL CRP-XL-induced platelet
aggregation (Fig 2D and 2E). This data confirms the ability of CAMP to affect human platelet
activation.
CAMP induces haemorrhage and fluctuations in muscle size in mice
In order to determine the mechanisms through which SVMPs induce permanent muscle dam-
age, CAMP was used as a tool to determine its pathological effects in TA muscle of mice in
comparison with CTX. The intramuscular injection of CAMP induced haemorrhage in the
damaged muscles and thereby, caused swelling and increase in muscle weight after five days of
administration (Fig 3A and 3B). However, CTX did not induce haemorrhage or swelling
although the muscle weight was reduced compared to the controls at the same time point. In
contrast, after ten days of administration, muscle weight in CAMP-treated mice was decreased
similar to CTX-treated muscle (Fig 3A and 3C). These data demonstrate that CAMP is capable
of inducing haemorrhage and swelling and thereby, increases in muscle weight initially
although it decreases at a later time point.
Attenuated regeneration in CAMP-damaged muscle
We examined the cellular processes underpinning the morphology of skeletal muscle and
assessed muscle regeneration after damage induced by CAMP. Haematoxylin (H) and eosin
(E) staining facilitates the identification of cellular organisation within a tissue and also the
presence of fibres containing centrally located nuclei (CLN), which is an indicator of muscle
regeneration. Five days after tissue damage, muscles treated with CTX contained many large
fibres with CLN (Fig 4A). Furthermore, there were regions of high cell density between fibres
displaying CLN. In contrast, 5 days after CAMP damage the number of fibres with CLN was
less abundant and smaller than in CTX damaged muscle (Fig 4A and 4B). Additionally, there
were areas of sparsely populated regions between fibres. Ten days after CTX damage, large
Fig 1. Purification of CAMP from the venom of C. atrox. A, A chromatogram demonstrates the purification profile of 10mg of whole C. atrox
venom by anion exchange chromatography. B, a Coomassie stained gel displays the protein profile of whole C. atrox venom and fractions 11–18 of
anion exchange chromatography. A chromatogram (C) and Coomassie stained gel (D) show the purification profile of fractions 14–18 of anion
exchange chromatography by gel filtration. E, a chromatogram of the second step of gel filtration for fractions 62–67 from the previous step and (F)
a Coomassie stained gel shows the purified protein at approximately 50kDa. G, the tryptic digested samples of the purified protein were analysed by
mass spectrometry and the identified peptide sequences match (via Mascot search) with the known sequence of VAP2A (coverage 43%; the mass
spectrometry-identified peptide sequences of the purified protein are shown in red) and confirms that the purified protein is most likely to be VAP,
a group III metalloprotease. The purified protein was named as CAMP to represent C. atrox metalloprotease.
https://doi.org/10.1371/journal.pntd.0007041.g001
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Fig 2. The functional characterisation of CAMP. A, the serine protease activity of 10μg/mL whole venom or CAMP was analysed using a fluorogenic substrate, Nα-
Benzoyl-L-Arginine-7-Amido-4-methylcoumarin hydrochloride (BAAMC) by spectrofluorimetry. Similarly, (B) the metalloprotease activity of 10μg/mL whole venom
or CAMP was analysed using DQ-gelatin, a specific fluorogenic substrate for collagenolytic enzymes and the level of fluorescence was measured by spectrofluorimetry.
C, a Coomassie stained gel demonstrates the fibrinogenolytic activity of CAMP in comparison with whole C. atrox venom. Lanes, 1—undigested fibrinogen, 2—
fibrinogen incubated with whole venom (100μg/mL), fibrinogen incubated with CAMP (100μg/mL) after 30 (3), 60 (4) and 90 (5) minutes, fibrinogen incubated with
CAMP (50μg/mL) after 30 (6), 60 (7) and 90 (8) minutes, and CAMP alone (9). Representative aggregation traces (D) and data (E) demonstrate the impact of CAMP on
cross-linked collagen related peptide (CRP-XL)-induced human platelet (PRP) aggregation. Data represent mean ± S.D. (n = 3). The p values shown are as calculated by
One-way ANOVA followed by post hoc Tukey’s test using GraphPad Prism (��p<0.01, ���p<0.001 and ����p<0.0001).
https://doi.org/10.1371/journal.pntd.0007041.g002
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fibres with CLN were evident with very little space between muscle fibres (Fig 4C and 4D).
The fibres appeared to be regular in terms of shape and size, evidencing robust muscle regen-
eration. Whereas, at the same time point, muscle damaged with CAMP displayed smaller
fibres with CLN and inter-fibre regions populated with cells were prominent (Fig 4C and 4D).
Next, we documented the profile of dying muscle fibres, facilitating the infiltration of circulat-
ing immunoglobulins (Ig) into the damaged fibres. Five days after CTX injection, low density
of small calibre fibres displayed the infiltration by IgG (Fig 4E–4G). In contrast, at the same
time point, CAMP treatment resulted in not only a higher density of fibres with infiltrated
IgG, but they were also of larger size (Fig 4E–4G). By day 10, very few dying fibres were present
in CTX treated muscle, however dying fibres were prominent in CAMP treated muscles (Fig
4H and 4I). We then examined the presence of regenerating muscle fibres, facilitated through
the expression of embryonic myosin heavy chain protein (MYH3). Muscle regeneration was
clearly evident in muscles damaged by CTX at day 5 (Fig 4J and 4K). Large numbers of evenly
sized fibres expressing MYH3 featured in CTX-damaged tissue (Fig 4J and 4L). In contrast to
CTX treatment, the number of regenerating fibres in CAMP-treated muscle was lower and
when present were of heterogeneous size (Fig 4J–4L). By Day 10, the expression of MYH3 has
been cleared in CTX-damaged muscle and when present was in very large fibres (Fig 4M–4O).
In contrast, MYH3 expression was clearly evident at day 10 in CAMP-damaged muscle but in
smaller, non-uniform fibres (Fig 4M–4O). Next, we examined the impact of CAMP and CTX
on blood vessels through immunostaining with the endothelial cell specific antibody, CD31.
Fig 3. Macrostructure of tibialis anterior muscle after CAMP treatment. A, representative images of muscles treated with either CTX or CAMP for 5 or 10 days.
Quantification of TA weight at 5 (B) and 10 (C) days post administration. Scale bar represents 5 mm. Data represent mean ± S.D. (n = 5 for each cohort). The p values
shown are as calculated by One-way ANOVA followed by post hoc Tukey’s test using GraphPad Prism (�p<0.05, ��p<0.01 and ���p<0.001).
https://doi.org/10.1371/journal.pntd.0007041.g003
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At both 5 and 10 days, the number of capillaries serving each regenerating fibre was greater in
the CTX treated sample compared to CAMP (Fig 4P–4S). Importantly, the number of capillar-
ies serving each regenerating fibre in the CTX treated sample was identical to the undamaged
sample. Moreover, the degree of macrophage infiltration into the damaged area was analysed,
as these cells are key to effective muscle regeneration. The density of macrophages in damaged
muscle was greater in the CTX treated muscle compared to CAMP at day 5 (Fig 4T and 4U).
However, by day 10, the situation was reversed; there was a greater density of macrophages in
the CAMP treated samples compared to CTX (Fig 4V and 4W).
CAMP extensively damages the extracellular matrix (ECM) surrounding
the myofibres
Efficient regeneration of skeletal muscle following acute damage is contingent on stem cells
capable of replacing damaged tissue and their highly ordered formation into myotubes/fibres,
a process orchestrated by the ECM. The organisation of collagen IV, a major BM component
of muscle fibres was analysed as described previously [39]. A thin circle of collagen IV sur-
rounding muscle fibre was evident 5 days after CTX treatment (Fig 5A). In contrast, at an
Fig 4. Analysis of tibialis anterior muscle regeneration after administration of CAMP or CTX. A, H and E staining of muscle identifying centrally located fibre nuclei
(CLN) (arrows) and (B) quantification of centrally located muscle fibre size 5 days post administration. C, H and E staining of muscle (arrows) and (D) quantification of
centrally located muscle fibre size 10 days post administration. E, intra-fibre IgG localisation for necrotic muscle fibres (arrows) and quantification of necrotic fibre
density (F) and size (G) 5 days post administration. H, intra-fibre IgG localisation for necrotic fibres (arrows) and (I) quantification of necrotic fibre density 10 days post
administration. J, identification of regenerating muscle fibres through the expression of MYH3 (arrows) and quantification of regenerating muscle fibre density (K) and
size (L) 5 days post administration. M, identification of regenerating muscle fibres through the expression of MYH3 (arrows) and quantification of regenerating muscle
fibre density (N) and size (O) 10 days post administration. P, Localisation of endothelial marker CD31 and (Q) quantification of capillaries per regenerating muscle fibre
5 days post administration. R, localisation of endothelial marker CD31 and (S) quantification of capillaries per regenerating muscle fibre 10 days post administration. T,
immunostaining with antibody F4/80 and (U) its density quantification in damaged region 5 days post administration. V, immunostaining with antibody F4/80 and (W)
its density quantification in damaged region 10 days post administration. Data represent mean ± S.D. (n = 5 for each cohort). The p values shown are as calculated by two-
tailed Student’s T test for independent variables using GraphPad Prism (�p<0.05, ��p<0.01 and ���p<0.001).
https://doi.org/10.1371/journal.pntd.0007041.g004
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identical time after CAMP treatment, muscle displayed large irregular, thick depositions of
collagen IV (Fig 5A and 5B) but by day 10, the picture was even more polarised, as CTX-dam-
aged muscle showed a relatively normal distribution of collagen IV (Fig 5C and 5D). In con-
trast, very few fibres from CAMP-treated muscle (at day 10) displayed a ring of collagen IV,
and instead this protein was localised at thick foci (Fig 5C and 5D). A near-identical pattern
was documented for the distribution of laminin, another major component of the muscle fibre
ECM (Fig 5E–5H).
Furthermore, the impact of CTX and CAMP on molecules that are associated with linking
the contractile apparatus to the ECM was investigated. Dystrophin is normally localised under
the sarcolemma of mature muscle fibres. Its expression was evident around some of the larger
Fig 5. Immunohistochemical analysis of muscle extracellular matrix and associated proteins after tibialis anterior damage with CAMP or CTX. Localisation
(arrows) (A) and thickness (B) of collagen IV 5 days post administration. Similarly, localisation (arrows) (C) and thickness (D) of collagen IV 10 days post injury. Note:
CTX damaged tissues show circumferential collagen compared to foci in CAMP treatment. Localisation (arrows) (E) and thickness (F) of laminin 5 days post injury.
Localisation (arrows) (G) and thickness (H) of laminin 10 days post injury. I, localisation of dystrophin 5 days post injury (arrows). Note: dystrophin around centrally
located nuclei in CTX-treated muscle. In contrast, incomplete dystrophin domain around CAMP-damaged muscle. J, intensity of dystrophin 5 days post injury.
Localisation (arrows) (K) and intensity (L) of dystrophin 10 days post injury. M, localisation of nNOS 5 days post injury (no circumferential nNOS was detectable at day 5)
and (N) thickness of nNOS 5 days post injury. O, localisation of nNOS 10 days post administration (arrows). Note: circumferential nNOS was only detectable in CTX-
treated muscle and (P) intensity of nNOS 10 days post injury. Localisation of CAMP in damaged region at day 5 (Q) and 10 (R) (arrows). Data represent mean ± S.D.
(n = 5 for each cohort). The p values shown are as calculated by One-way ANOVA followed by post hoc Tukey’s test using GraphPad Prism (�p<0.05, ��p<0.01 and
���p<0.001). CNT represents control.
https://doi.org/10.1371/journal.pntd.0007041.g005
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regenerating muscle fibres 5 days after CTX damage (Fig 5I). Whereas, very few fibres express-
ing dystrophin were detected at a similar time point in CAMP-treated muscles (Fig 5I). How-
ever, when present, the thickness of the dystrophin expression domain was similarly reduced
by the two treatments (Fig 5J). At day 10, most of the fibres from CTX-treated muscle dis-
played a continuum of dystrophin expression, although at a lower thickness compared to
undamaged tissue (Fig 5K and 5L). However, very few fibres with a ring of dystrophin were
present in CAMP-treated muscles at day 10 (Fig 5K). Furthermore, the domain, when present
was thinner than both control as well as CTX treated muscles (Fig 5L). Then, the distribution
of nNOS, a protein that localises to a sub-sacrolemmal position which is dependent on its
binding to dystrophin was assessed. At 5 days after treatment, very little nNOS was present in
either CTX or CAMP-damaged muscles (Fig 5M and 5N). By day 10, a thin band of nNOS was
evident in CTX-treated muscle but not in the muscle damaged by CAMP (Fig 5O and 5P).
Lastly, the muscles were analysed to determine the presence of remaining CAMP in damaged
tissues. The immunohistological profiling showed that CAMP was clearly present at both 5
and 10 days after its administration (Fig 5Q and 5R). These results show that CAMP treatment
damages not only the ECM of muscle fibres but also affects intracellular components that link
it to the contractile machinery.
CAMP affects the functions of satellite cells (SCs)
The role of SCs adjacent to the muscle fibres is critical for muscle regeneration. In order to
determine the impact of CAMP on SCs, we have isolated myofibres from intact EDL muscles
and exposed them to a range of concentrations of CAMP. As early as 24 hours after CAMP
treatment, it was evident that there was a concentration dependent disturbance to the collagen
component of the ECM around muscle fibres. A uniform layer of collagen expression was
detected in untreated fibres (Fig 6A). At the lower concentration, CAMP caused a localised
denuding of the myofibre (Fig 6B), whereas the higher concentration resulted in the absence
of collagen from most parts of the fibres and caused it to concentrate in specific locations (Fig
6C). The cell growth, proliferation and migration were monitored on the isolated single mus-
cle myofibres over a 48 hour time period. SCs were immunostained using the myogenic tran-
scription factors, Pax7 (uncommitted cells) and MyoD (activated cells) in order to monitor the
progression of cells through myogenesis. The concentrations of above 0.3μM of CAMP
induced hypercontraction, which is indicative of extensive fibre damage. At 0.3μM, viable
fibres were present, and revealed that CAMP significantly decreased the number of associated
SCs (Fig 6D). Furthermore, the number of SC clusters was reduced per fibre (Fig 6E), although
each cluster at the lower concentration had more cells than untreated fibres (Fig 6F). Analysis
of differentiation was only possible at the lowest concentration of CAMP (Fig 6G) as at higher
concentrations, hypercontraction prevented this analysis. The migration speed was calculated
between 24 and 48 hours and was found to decrease significantly as the concentration of
CAMP increased (Fig 6H). These data demonstrate that CAMP is able to affect both the prolif-
eration and migration of SCs but not the differentiation.
Discussion
The swelling and necrosis at the bite site as well as permanent muscle damage are common
effects of snakebite envenomation (particularly viper bites). These effects frequently lead to
amputation and therefore disable victims, which adds to their inability to earn money, and
exacerbates the poverty that is already experienced by the vast majority of snakebite victims
[4]. Here we have purified a metalloprotease from one of the most studied venomous snake
species, C. atrox. Although deaths from this snake are now uncommon, disfigurement is still a
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prevalent side effect for survivors. SVMPs are a predominant component in viper venoms that
are involved in inducing the local envenomation effects including muscle damage. The ability
of SVMPs to degrade collagen has been established, but its impact on permanent muscle dam-
age under in vivo settings has not been previously demonstrated in sufficient detail. Therefore,
Fig 6. CAMP treatment affects proliferation and migration of satellite cells. (A-C) Increasing concentrations of CAMP change the distribution of collagen IV. Satellite
cell proliferative characteristics following CAMP treatment were analysed. For example, satellite cell number per fibre (D), satellite cell clusters per fibre (E) and cluster
size per fibre (F) were quantified. G, myogenic characteristics of satellite cells following CAMP treatment. H, migration rate of satellite cells. Scale bar represents 20μm.
Data represent mean ± S.D. (n = 20 fibres for each cohort). The p values shown are as calculated by One-way ANOVA followed by post hoc Tukey’s test using GraphPad
Prism (�p<0.05, ��p<0.01 and ���p<0.001). CNT represents control.
https://doi.org/10.1371/journal.pntd.0007041.g006
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we deployed a metalloprotease from the venom of C. atrox and analysed its impact on skeletal
muscle damage in comparison to a three-finger toxin, CTX from the venom of Naja pallida.
Mass spectrometry analysis of the purified protein suggests it to be a group III metalloprotease,
which possess a metalloprotease domain as well as a disintegrin-like and cysteine-rich domains
[40]. Based on the peptide sequences identified by the mass spectrometry, the purified protein is
likely to be VAP2 or one of its heterodimers; VAP2A or VAP2B, both of which are vascular apo-
ptosis inducing proteins (38) that are known to be haemorrhagic [41] and in the case of VAP2B
to inhibit collagen-induced platelet activation [42]. Due to the limited peptide sequences identi-
fied by mass spectrometry for the purified protein, we are unable to conclude whether the puri-
fied protein (CAMP) is identical to VAP2 or either of its heterodimers. CAMP was characterised
to be a collagenolytic and fibrinogenolytic enzyme. It also inhibited CRP-XL-induced platelet
aggregation; group III metalloproteases are known to interact with the integrin α2β1, binding to
the α2 subunit and causing the shedding of β1 subunits [43]. However, VAP2B (a protein
described from C. atrox) has been reported to inhibit collagen induced platelet aggregation by
binding to collagen [44], although whether the SECD sequence found in disintegrin-like
domains is able to bind CRP-XL in the same way, is unknown.
In order to determine the impact of SVMPs in stimulating permanent muscle damage, dif-
ferent concentrations of CAMP were administered in mice along with CTX and control
groups and the effects were analysed at five and ten days after the administration. We suggest
that this occurs at two levels; by breaking down the ECM which normally acts as a scaffold for
the formation of new muscle fibres and around existing blood vessels and secondly attenuating
properties of resident stem cells that are essential to effective tissue repair. SVMPs are known
for their collagenolytic activities and for targeting various components of the BM in the vascu-
lature and inducing haemorrhage [45]. In line with previous studies, here we demonstrate that
CAMP induces haemorrhage and affects the architecture of collagen and laminin. The destruc-
tion of the collagen based ECM may be the key to long-term tissue destruction wrought by
CAMP. The disintegrin-like and cysteine-rich domains have already been identified as essen-
tial to the haemorrhagic activity and ECM degradation attributed to the PIII metalloproteases
[46]. This is in contrast to myotoxic PLA2 and three-finger toxins that are well documented in
causing membrane permeabilisation and consequentially myonecrosis via the hydrolysis of
membrane phospholipids or imbedding directly into the membrane respectively [47–49]. Our
data emphasise that CAMP in comparison to CTX significantly hindered the regeneration of
skeletal muscle fibres most probably by disturbing the organisation of the ECM. The elevated
levels of necrosis seen five days after administration with CAMP improved after ten days,
although it was still evident. However, it must be noted that at day 10, the CTX treated muscles
had almost completely regenerated with healthy fibres. Moreover, very low levels of MYH3
were detected five days after CAMP treatment. In CTX-treated muscles, this marker of regen-
erating fibres was clearly evident and present at a high level. This indicates that the initiation
of the regeneration process was attenuated by CAMP in comparison to CTX. Muscle regenera-
tion is dependent on blood supply and clearance of damaged fibres. We show here that both
these cellular compartments are affected in a detrimental manner by CAMP. We found that
the number of capillaries serving each regenerating muscle fibre was smaller in CAMP treated
muscle compared to CTX. Importantly the number of capillaries serving each fibre in damaged
CTX muscle was the same as in undamaged regions. These results show that capillaries as well
as muscle fibres are damaged by CAMP whereas it is only the latter in CTX treated tissue.
Additionally, we show that there was a greater influx of macrophages into the CTX damaged
muscle compared to regions affected by CAMP. Furthermore, the density of macrophages
decreased in CTX treated muscle over time, attesting to regeneration. In contrast, the density
of macrophages in CAMP treated muscle was lower at day 5 compared to CTX, possibly
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indicating an attenuated clearance process. Importantly the density of macrophages did not
change in the CAMP treated muscle over 10 days suggesting on-going muscle damage.
Although the abundance of MYH3 increased in CAMP-treated muscles by day 10, its expres-
sion in CTX-injured muscles was almost undetectable, signifying advanced regeneration. This
was reflected in the appearance of dystrophin and nNOS at their normal sub-sarcolemmal
position. In keeping with the notion that CAMP treatment not only affects the degree of regen-
eration but also its timing, we showed that very few fibres expressed dystrophin in its normal
position and a significantly reduced expression of nNOS was observed even at day 10. Most
importantly we show that CAMP is still present at the site of injury even 10 days after its
administration and that it profoundly disorganises the ECM.
The single fibre experiments highlight another aspect to explain the attenuated muscle
regeneration following CAMP-mediated muscle damage. We demonstrate that the prolifera-
tion and migration of SCs was significantly reduced by CAMP treatment. Both of these factors
are key in promoting muscle regeneration. Therefore, CAMP may bring about permanent
impairment of muscle organisation and function by firstly destroying muscle fibres, secondly
breaking down the organisation of the ECM. This is required by the SCs in order to align and
fuse in a coordinated manner and lastly by diminishing the ability for SCs to expand their
numbers and migrate to the site of injury to enact efficient regeneration. It is clear that current
ASV treatment is not effective at preventing muscle damage. Although translating the results
of this study into therapeutics might be difficult, these will improve the understanding of
SVMP-induced permanent muscle damage. The ability of group III metalloproteases to bind
components of the BM and prolong muscle exposure to their myotoxic effects suggests a thera-
peutic agent that is capable of interacting with these enzymes and non-enzymatic domains and
preventing the longevity of these proteins in the area surrounding fibres may be able to speed
up the rate of regeneration considerably. Moreover, any drugs aimed at treating this aspect of
snakebite envenomation may struggle to reach it intravenously, and therefore, they may have
to be administered via multiple local injections considering the widespread damage to micro-
vasculature [32] and consequential lack of blood supply to affected tissues.
ASV is the only effective treatment for systemic envenoming, however local venom pathol-
ogy is largely unaffected by ASV when treatment is not immediately administered [50]. ASV is
composed of large immunoglobulins that appear to struggle to reach the areas affected by
SVMPs. The combination of small vessel destruction combined with BM cleavage results in a
poor blood supply and therefore weak neutralisation by intravenously administered ASV.
Local injections of ASV have also been found to be of no benefit to the snakebite victims [51].
However, there are a range of matrix metalloprotease inhibitors that have undergone testing
for their specificity to SVMPs and some promising compounds have been identified [52]. The
small molecule inhibitors aimed at the metalloprotease domain such as batimastat [53] have
been tested extensively and they were found to abrogate the haemorrhagic effects of venom if
administered immediately after envenoming. Given their haemorrhagic effects are largely
dependent upon collagen degradation, it is reasonable to postulate that this prevention of hae-
morrhagic effects may also apply to muscle damage. Moreover, metal chelating agents such as
EDTA have also been tested in vivo at non-toxic doses and found to prevent venom-induced
lethality [54].
The need for immediate administration is of course unrealistic with conventional ASV but
small stable inhibitors have the potential to be spread and made available to those in areas with
a high density of snakebites. Multiple local injections do bring the potential for delivery
directly to the bite site and administering to multiple sites may overcome the problematic
spread of drug through a site of damaged muscles and vessels. Future experiments should aim
to investigate the effect of these drugs on BM components, using both pre-incubation with
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drugs and post envenomation delivery models. Overall, the complete destruction or loss of a
range of BM and dystrophin-glycoprotein complex components as well as the effect of this
SVMP on muscle regeneration highlights the significant difficulties involved in treating the
necrosis and muscle damage associated with snakebite envenomation. Hence, this study pro-
vides greater insights into the understanding of SVMP-induced permanent muscle damage
and local snakebite envenomation effects.
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